Pharmaceutical Rsrch & Mfrs of America
Pharmaceutical Research and Manufacturers of America (PhRMA), founded in 1958, is a trade group representing the pharmaceutical research and biotechnology companies in the United States. PhRMA's stated mission is advocacy for public policies that encourage the discovery of new medicines for patients by pharmaceutical and biotechnology research companies. PhRMA's current CEO is John J. Castellani.
Source: Wikipedia
Campaign Finance
$83,763,092 GivenFigures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars. "Other" includes 3rd parties and organizations without official party affiliation. -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Bundled Contributions
Money raised by the firm from multiple donors on behalf of the recipient. The firm's own contributions are not included.Recipient Lobbyist Amount National Republican Senatorial Cmte Jennifer A. Swenson $32,500
Lobbying
$230,213,920 SpentFigures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Pharmaceutical Rsrch & Mfrs of America
-
Names of Lobbyists
-
Firm Hired Amount Pharmaceutical Rsrch & Mfrs of America $228,223,920 Brown & Assoc $20,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Pharmacy,
- Trade,
- Fed Budget & Appropriations,
- Medical Research & Clin Labs,
- Taxes,
- Consumer Product Safety,
- Advertising
-
Most Frequently Disclosed Bills
Bill No. Title H.R.3590 Service Members Home Ownership Tax Act of 2009 H.R.1548 Pathway for Biosimilars Act H.R.1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R.3200 America's Affordable Health Choices Act of 2009 S.515 Patent Reform Act of 2009 H.R.1260 Patent Reform Act of 2009 H.R.4872 Health Care and Education Affordability Reconciliation Act of 2010 H.R.3962 Affordable Health Care for America Act S.726 Promoting Innovation and Access to Life-Saving Medicine Act S.23 Patent Reform Act of 2011 -
Recent Lobbying Contracts
Date Registrant Summary April 2, 2013 Prime Policy Group Issues related to Medicare and healthcare. View registration
Regulations
Mentioned in 467 dockets; Submitted to 129 docketsAll data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Pharmaceutical Rsrch & Mfrs of America" in public comments on proposed federal regulations.
-
Documents Submitted by the Organization
View all submissions data for Pharmaceutical Rsrch & Mfrs of America
Sources:
Regulations.gov
-
Mentions in Document Text
View all mentions data for Pharmaceutical Rsrch & Mfrs of America
Sources:
Regulations.gov
Advisory Committees
2 people on 1 committeeData is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Pharmaceutical Rsrch & Mfrs of America" that sat on federal advisory committees.
View all advisory committee data for Pharmaceutical Rsrch & Mfrs of America